Mesothelioma

Also known as: Mesotheliomas

DrugDrug NameDrug Description
DB00305MitomycinAn antimetabolite used as an adjunct to ab externo (outside approach) eye surgeries for the treatment of glaucoma and used as a chemotherapeutic agent for various malignancies.
DB00642PemetrexedA folate analog used to treat mesothelioma and non-small cell lung cancer.
DrugDrug NamePhaseStatusCount
DB06122Amatuximab0Terminated1
DB12845Amatuximab0Terminated1
DB09155Helium0Not Yet Recruiting1
DB00556Perflutren0Not Yet Recruiting1
DB11104Sulfur hexafluoride0Not Yet Recruiting1
DB13453Xenon0Not Yet Recruiting1
DB15074Aglatimagene besadenovec1Active Not Recruiting1
DB03496Alvocidib1Terminated1
DB06122Amatuximab1Completed2
DB12845Amatuximab1Completed1
DB00928Azacitidine1Unknown Status1
DB06616Bosutinib1Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB00515Cisplatin1Completed2
DB00515Cisplatin1Not Yet Recruiting1
DB00515Cisplatin1Recruiting1
DB00515Cisplatin1Terminated1
DB00531Cyclophosphamide1Recruiting1
DB01234Dexamethasone1Completed1
DB01248Docetaxel1Active Not Recruiting1
DB11714Durvalumab1Recruiting1
DB15017Enoblituzumab1Completed1
DB15017Enoblituzumab1Recruiting1
DB01590Everolimus1Active Not Recruiting1
DB00619Imatinib1Completed1
DB06186Ipilimumab1Completed1
DB00762Irinotecan1Recruiting1
DB12807Naptumomab Estafenatox1Recruiting1
DB09035Nivolumab1Recruiting1
DB01229Paclitaxel1Active Not Recruiting2
DB06603Panobinostat1Completed1
DB09037Pembrolizumab1Not Yet Recruiting1
DB09037Pembrolizumab1Recruiting2
DB00642Pemetrexed1Completed2
DB00642Pemetrexed1Not Yet Recruiting1
DB00642Pemetrexed1Recruiting2
DB00642Pemetrexed1Terminated1
DB00020Sargramostim1Recruiting1
DB00398Sorafenib1Completed1
DB15232Telaglenastat1Active Not Recruiting1
DB00853Temozolomide1Unknown Status1
DB00577Valaciclovir1Active Not Recruiting1
DB00041Aldesleukin1 / 2Terminated1
DB00112Bevacizumab1 / 2Terminated1
DB15286CB-11581 / 2Recruiting1
DB00958Carboplatin1 / 2Terminated1
DB00515Cisplatin1 / 2Recruiting1
DB00515Cisplatin1 / 2Withdrawn1
DB00531Cyclophosphamide1 / 2Completed1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Terminated1
DB12282Defactinib1 / 2Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB06186Ipilimumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting2
DB09037Pembrolizumab1 / 2Withdrawn1
DB00642Pemetrexed1 / 2Recruiting1
DB00642Pemetrexed1 / 2Terminated1
DB00642Pemetrexed1 / 2Withdrawn1
DB00552Pentostatin1 / 2Completed1
DB11759Pevonedistat1 / 2Recruiting1
DB06810Plicamycin1 / 2Recruiting1
DB15185Rasdegafusp alfa1 / 2Withdrawn1
DB05220Alisertib2Active Not Recruiting1
DB14809Anetumab ravtansine2Completed1
DB00112Bevacizumab2Completed3
DB00188Bortezomib2Unknown Status1
DB08870Brentuximab vedotin2Recruiting1
DB00958Carboplatin2Completed2
DB00958Carboplatin2Recruiting1
DB00515Cisplatin2Approved for Marketing1
DB00515Cisplatin2Completed1
DB00515Cisplatin2Recruiting2
DB00515Cisplatin2Terminated1
DB00515Cisplatin2Unknown Status1
DB00531Cyclophosphamide2Recruiting1
DB01234Dexamethasone2Unknown Status1
DB01142Doxepin2Terminated1
DB11714Durvalumab2Active Not Recruiting2
DB11714Durvalumab2Suspended1
DB00530Erlotinib2Completed1
DB01073Fludarabine2Recruiting1
DB00544Fluorouracil2Completed1
DB00317Gefitinib2Completed1
DB00441Gemcitabine2Active Not Recruiting1
DB00441Gemcitabine2Completed3
DB00441Gemcitabine2Recruiting1
DB00441Gemcitabine2Unknown Status1
DB00619Imatinib2Unknown Status1
DB06186Ipilimumab2Active Not Recruiting1
DB00563Methotrexate2Recruiting1
DB12334Milataxel2Unknown Status1
DB01204Mitoxantrone2Completed1
DB11793Niraparib2Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB09074Olaparib2Recruiting1
DB00526Oxaliplatin2Completed1
DB00526Oxaliplatin2Unknown Status1
DB01229Paclitaxel2Completed1
DB09037Pembrolizumab2Recruiting1
DB00642Pemetrexed2Approved for Marketing1
DB00642Pemetrexed2Completed5
DB00642Pemetrexed2Recruiting2
DB00642Pemetrexed2Terminated1
DB00642Pemetrexed2Unknown Status1
DB06810Plicamycin2Terminated1
DB05578Ramucirumab2Active Not Recruiting1
DB00398Sorafenib2Unknown Status1
DB12887Tazemetostat2Completed1
DB12887Tazemetostat2Recruiting1
DB11771Tremelimumab2Active Not Recruiting1
DB11771Tremelimumab2Suspended1
DB05294Vandetanib2Terminated1
DB00361Vinorelbine2Active Not Recruiting1
DB00361Vinorelbine2Completed1
DB00361Vinorelbine2Terminated1
DB00399Zoledronic acid2Completed1
DB00112Bevacizumab2 / 3Completed1
DB00515Cisplatin2 / 3Completed1
DB00515Cisplatin2 / 3Recruiting2
DB00515Cisplatin2 / 3Terminated1
DB09079Nintedanib2 / 3Terminated1
DB06592Pegargiminase2 / 3Recruiting1
DB09037Pembrolizumab2 / 3Recruiting1
DB00642Pemetrexed2 / 3Completed1
DB00642Pemetrexed2 / 3Recruiting2
DB00642Pemetrexed2 / 3Terminated1
DB00958Carboplatin3Active Not Recruiting1
DB00515Cisplatin3Active Not Recruiting1
DB06186Ipilimumab3Active Not Recruiting1
DB09035Nivolumab3Active Not Recruiting1
DB09035Nivolumab3Recruiting1
DB00642Pemetrexed3Active Not Recruiting1
DB00642Pemetrexed3Completed1
DB02546Vorinostat3Completed1
DB00642Pemetrexed4Recruiting2
DB06151AcetylcysteineNot AvailableUnknown Status1
DB08818Hyaluronic acidNot AvailableCompleted1
DB01249IodixanolNot AvailableTerminated1
DB01362IohexolNot AvailableTerminated1